Twin Study of Lifetime Major Depression
A Swedish National Twin Study of Lifetime Major Depression.
Am J Psychiatry 163:109-114, January 2006.
Republished by Blog Post Promoter
A Swedish National Twin Study of Lifetime Major Depression.
Am J Psychiatry 163:109-114, January 2006.
Republished by Blog Post Promoter
Depressive disorders and immunity: 20 years of progress and discovery.
Brain Behav Immun. 2007 May;21(4):374-83. Epub 2007 Mar 13.
Republished by Blog Post Promoter
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.
Neuropsychopharmacology. 2006 Nov;31(11):2505-13. Epub 2006 Jun 7.
Republished by Blog Post Promoter
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.
CMAJ February 3, 2009; 180 (3).
A meta-analysis of 8 large-scale observational studies involving more than 200 000 patients with moderate or severe depression.
“…children and adolescents should be followed very closely because of the possibility of increased of risk suicidal thoughts and suicide. Paroxetine and venlafaxine may be better avoided based on the increasing evidence from randomized and observational studies that the risks might outweigh the benefits for most adolescents.”
Republished by Blog Post Promoter
Descriptive epidemiology of major depression in Canada.
The lifetime prevalence of major depressive episode was 12.2%.
Republished by Blog Post Promoter
A neurotrophic model for stress-related mood disorders.
Biol Psychiatry. 2006 Jun 15;59(12):1116-27. Epub 2006 Apr 21.
Republished by Blog Post Promoter
Life events, first depression onset and the serotonin transporter gene.
The British Journal of Psychiatry (2006) 188: 210-215.
Republished by Blog Post Promoter
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.
Biol Psychiatry. 2008 Sep 15;64(6):527-32. Epub 2008 Jun 24.
Republished by Blog Post Promoter
Escitalopram and Problem-Solving Therapy for Prevention of Poststroke Depression
JAMA. 2008;299(20):2391-2400.
Related News:
JAMA Announces Gag Rule on Conflict-of-Interest Whistleblowers -MedPage Today.
-updated 2009/03/26
Republished by Blog Post Promoter